$MIRM

3 theses

bullish 0%neutral 0%bearish 100%

Avg return (3m)

—

Win rate (3m)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Nov 9, 11:30 AM ET

$MIRMSEC Form 4bearish

Brege Laura · Mirum Pharmaceuticals, Inc. · 20h agono track record yet

Sold 14,167 @ $94.21 avg · $1,334,656 · 2026-11-11

Form 4: Brege Laura sold MIRM

Brege Laura (Director at Mirum Pharmaceuticals, Inc.) reported an open-market sale of 14,167 shares of MIRM at an average $94.21, roughly $1,334,656, in a Form 4 filed 2026-11-13.

At post $93.99Now $92.35-1.7% since postedas of Nov 9, 11:30 AM ET

View filing on SEC.gov →

$MIRMSEC Form 4bearish

BJERKHOLT ERIC · CHIEF FINANCIAL OFFICER at Mirum Pharmaceuticals, Inc. · 60d agono track record yet

Sold 9,943 @ $98.37 avg · $978,093 · 2026-09-14

Form 4: BJERKHOLT ERIC sold MIRM

BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER at Mirum Pharmaceuticals, Inc.) reported an open-market sale of 9,943 shares of MIRM at an average $98.37, roughly $978,093, in a Form 4 filed 2026-09-15.

At post $93.90Now $92.35-1.6% since postedas of Nov 9, 11:30 AM ET

1d+3.7%

3d-2.2%

1w-2.7%

1m-12.3%

3m—

6m—

1y—

View filing on SEC.gov →

$MIRMSEC Form 4bearish

Howe Jolanda · SVP, GLOBAL CONTROLLER at Mirum Pharmaceuticals, Inc. · 87d agono track record yet

Sold 40,000 @ $100.00 avg · $4,000,000 · 2026-08-18

Form 4: Howe Jolanda sold MIRM

Howe Jolanda (SVP, GLOBAL CONTROLLER at Mirum Pharmaceuticals, Inc.) reported an open-market sale of 40,000 shares of MIRM at an average $100.00, roughly $4,000,000, in a Form 4 filed 2026-08-19.

At post $102.24Now $92.35-9.7% since postedas of Nov 9, 11:30 AM ET

1d-5.1%

3d-5.8%

1w-3.6%

1m-10.2%

3m—

6m—

1y—

View filing on SEC.gov →

End of results.